Peer-Reviewed Publications

CPCE investigators are international experts in their clinical effectiveness-related fields, and have authored hundreds of pediatric research articles in leading peer-reviewed journals. From here you can access CPCE journal article abstracts by author, title, or year.

Found 127 results
Author Title [ Year(Asc)]
Search results for Aplenc  [Reset Search]
2020
Aplenc R, Meshinchi S, Sung L, et al. "Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children's Oncology Group." Haematologica. 2020.
Ding Y-Y, Ramakrishna S, Long AH, et al. "Delayed cancer diagnoses and high mortality in children during the COVID-19 pandemic." Pediatr Blood Cancer. 2020:e28427.
Diorio C, Shaw PA, Pequignot E, et al. "Diagnostic biomarkers to differentiate sepsis from cytokine release syndrome in critically ill children." Blood Adv. 2020;4(20):5174-5183.
Getz KD, Sung L, Alonzo TA, et al. "Effect of Dexrazoxane on Left Ventricular Systolic Function and Treatment Outcomes in Patients With Acute Myeloid Leukemia: A Report From the Children's Oncology Group." J. Clin. Oncol.. 2020:JCO1902856.
Hoff FW, van Dijk AD, Qiu YHua, et al. "Heat Shock Factor 1 (HSF1-pSer326) Predicts Response to Bortezomib-Containing Chemotherapy in Pediatric AML: A COG Study." Blood. 2020.
Cahen VC, Li Y, Getz KD, et al. "Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment." Pediatr Blood Cancer. 2020:e28315.
Arnold SD, Brazauskas R, He N, et al. "The impact of donor type on outcomes and cost of allogeneic hematopoietic cell transplant for pediatric leukemia: a merged CIBMTR and PHIS analysis: Pediatric acute leukemia transplant risks and utilization." Biol. Blood Marrow Transplant.. 2020.
Brodersen LEidenschin, Gerbing RB, M Pardo L, et al. "Morphologic remission status is limited compared to ΔN flow cytometry: a Children's Oncology Group AAML0531 report." Blood Adv. 2020;4(20):5050-5061.
Cooper TM, Absalon MJ, Alonzo TA, et al. "Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group." J. Clin. Oncol.. 2020:JCO1903306.
Bona K, Li Y, Winestone LE, et al. "Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma." J Natl Cancer Inst. 2020.
Wang ES, Aplenc R, Chirnomas D, et al. "Safety of gemtuzumab ozogamicin as monotherapy or combination therapy in an expanded-access protocol for patients with relapsed or refractory acute myeloid leukemia." Leuk. Lymphoma. 2020:1-9.
Aplenc R. "Venetoclax for paediatric acute myeloid leukaemia: a step forward." Lancet Oncol.. 2020;21(4):476-478.
2019
Rafiee R, Chauhan L, Alonzo TA, et al. "ABCB1 SNP predicts outcome in patients with acute myeloid leukemia treated with Gemtuzumab ozogamicin: a report from Children's Oncology Group AAML0531 Trial." Blood Cancer J. 2019;9(6):51.
Surrey LF, MacFarland SP, Chang F, et al. "Clinical utility of custom-designed NGS panel testing in pediatric tumors." Genome Med. 2019;11(1):32.
Smith JL, Ries RE, Hylkema T, et al. "Comprehensive Transcriptome Profiling of Cryptic CBFA2T3-GLIS2 Fusion-positive AML Defines Novel Therapeutic Options - A COG and TARGET Pediatric AML Study." Clin. Cancer Res.. 2019.
Change F, Lin F, Cao K, et al. "Development and Clinical Validation of a Large Fusion Gene Panel for Pediatric Cancers." J Mol Diagn. 2019.
Winestone LE, Getz KD, Rao P, et al. "Disparities in pediatric acute myeloid leukemia (AML) clinical trial enrollment." Leuk. Lymphoma. 2019:1-9.
Winestone LE, Aplenc R. "Disparities in Survival and Health Outcomes in Childhood Leukemia." Curr Hematol Malig Rep. 2019.
Tarlock K, Alonzo TA, Wang Y-C, et al. "Functional Properties of KIT Mutations are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia." Clin. Cancer Res.. 2019.
Garcia-Pavia P, Kim Y, Restrepo-Cordoba MAlejandra, et al. "Genetic Variants Associated with Cancer Therapy-Induced Cardiomyopathy." Circulation. 2019.
Seif AE, Li Y, Monos DS, et al. "Partially CD3-depleted unrelated and haploidentical donor PSCT has favorable GVHD and survival rates in pediatric hematologic malignancy." Biol. Blood Marrow Transplant.. 2019.
Elgarten CW, Aplenc R. "Pediatric acute myeloid leukemia: updates on biology, risk stratification, and therapy." Curr. Opin. Pediatr.. 2019.
Andriescu ECorina, Coughlin CC, Cheng CE, et al. "Pediatric leukemia cutis: A case series." Pediatr Dermatol. 2019.
Nagarajan R, Gerbing R, Alonzo TA, et al. "Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group." Cancer Med. 2019.
Miller TP, Fisher BT, Getz KD, et al. "Unintended consequences of evolution of the Common Terminology Criteria for Adverse Events." Pediatr Blood Cancer. 2019:e27747.

Pages